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Mutations in keratin 9 have been found in families 
with an epidermolytic form of palmar-plantar kerato-
derma (PPK). In another form of PPK (Unna-Thost 
type), epidermolysis is not observed histologically. We 
studied a pedigree with this non-epidermolytic form 
of PPK. By gene linkage analysis, the type I keratin 
locus could be excluded but complete linkage with the 
type II keratin region was found. Sequence analysis 
identified a single base change in the amino-terminal 
Vi variable subdomain of keratin 1, which caused a 
lysine to isoleucine substitution. This non-conservative 
mutation completely co segregated with the disease 
and was not observed in 50 unrelated unaffected indi-
viduals. An examination of keratin amino-terminal 
sequences revealed a previously unreported 22-residue 
window in the Vi subdomain that is conserved among 
Palmar-plantar keratoderma (PPK) (tylosis) defines a group of heterogeneous disorders characterized by se-vere thickening of the epidermis of palms and soles. One type of PPK, also called U nna-Thost Disease [1,2], is inherited as an autosomal dominant disorder (McKusick 
148400). The disease is characterized by diffuse hyperkeratosis of 
the palms and soles, usually becoming evident by 12 months of age. 
This non-epidermolytic type of PPK (NEPPK) can be similar in 
clinical presentation to localized epidermolytic hyperkeratosis of 
the palms and soles as described by Vomer [3] (McKusick 144200). 
On light microscopy, affected skin from patients with NEPPK 
show orthokeratotic hyperkeratosis (thickened stratum corneum) 
and acanthosis (epidermal hyperplasia). In contrast, the epidermo-
lytic type of PPK (EPPK) exhibits hyperkeratosis, but is character-
ized by a distinctive vacuolar degeneration of the granular layer of 
the epidermis. 
Keratins constitute the major differentiation product of epider-
mal cells and are either acidic (type I) or neutral/basic (type II). 
They are expressed in specific type I/type II pairs characteristic of 
the stage ot differentiation of the keratinocyte. Three inherited 
disorders of the skin have been shown to be caused by mutation in 
genes encoding epidermal keratins. Epidermolysis bullosa simplex 
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most type II keratins. The altered lysine is an invariant 
residue in this conserved sequence. Previously de-
scribed keratin mutations affect the central regions 
important for filament assembly and stability, and 
cause diseases characterized by cellular degeneration 
or disruption. This is the first disease mutation in a 
keratin chain variable end region. The observation that 
it is not associated with epidermolysis supports the 
concept that the amino-terminal domain of keratins 
may be involved in supra molecular interactions of , 
keratin filaments rather than stability. Therefore, hy-
perkeratosis associated with this mutation may be due ' 
to perturbations in the interactions of the keratin end 
domain with other cellular components. ] Invest Der-
matol103:764-769,1994 
is caused by mutation in either of the keratins 5 or 14 that are 
expressed in basal epidermal cells (for review, see Fuchs [4]) . Gener-
alized epidermolytic hyperkeratosis can be due to mutation in either 
keratin 1 or 10 [5 -10] expressed in suprabasal epidermal cells. Most 
recently mutations in keratin 9, expressed in the suprabasal cells of 
palm and sole epidermis, have been reported in EPPK [11 ,12]. 
Using linkage and mutation analysis in a large family in which , 
the disease was segregating, we tested the hypothesis that NEPPK is 
another disorder of epidermal keratin. We identified a unique mu-
tation in the amino-terminal V1 end domain of keratin 1 as the 
likely cause of the disease. This is the first mutation in an end I 
domain of a keratin. The absence of cell fragility associated with this 
mutation distinguishes it from those mutations causing generalized 
epidermolytic hyperkeratosis, EPPK, and epidermolysis bullosa 
simplex. This finding demonstrates that keratin end domains have a 
significant role in the function of keratin intermediate filaments in 
the epidermis. 
MATERIALS AND METHODS 
Patients and Clinical Material This family was ascertained as part of a 
continuing effort to identify the etiology of a variety of ichthyoses. Blood 
and skin samples were obtained with informed consent under a protocol 
approved by the Institute IRB. Patient diagnosis was established by exami-
nation by a dermatologist, review of medical records, or reliable family 
information. Skin biopsies were obtained from four adult patients and exam-
ined with light and electronmicroscopy. 
Linkage Analysis NEPPK was modeled as an autosomal dominant, fully , 
penetrant disorder. Lod scores were fully robust over a wide range of disease 
allele frequencies. KRT10 and microsatellite marker allele frequencies were 
established from unrelated individuals in the NEPPK fami ly and many other 
reference families in our laboratory. Lod scores for the KRT1-V1 mutation 
were calculated using an allele frequency of 0.0 1 for the mutant allele based 
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Figure 1. Pedigree of NEPPK family. Solid symbols are people with 
NEPPK; opm symbols, unaffected subjects. Arrow indicates proband; horizoll-
tal bar above symbol indicates individual was examined by JJD; asterisk below 
symbol indicates individuals on whom DNA was analyzed; vertical slash 
through symbol indicates deceased individual. 
on observing no control individuals with the mutation in 100 alleles tested. 
computations were performed using the LINKAGE package of programs 
[13]. 
DNA Marker Analysis For the Southern blot analysis, 100 Ilg of ge-
nomic DNA was digested with the restriction enzyme MspI and the pre-
pared blots probed with 012S14 and D12S17 obtained from American Type 
Culture Collection (peFD 33.2 and p YNH 15). The microsatellite markers 
were amplified by PCR in 40 III reaction volumes containing 600 ng ge-
nomic DNA, 200 nM of each primer, 200 JIM of each dGTP, dATP, and 
dTTP, 25 JIM dCTP, 0.2 Jil of [32P]-a:-dCTP{3000 Ci/mmol), 1 U Ampli-
Taq DNA polymerase, 1 X buffer. cOlltai?ing 10 mM. Tris-HCl, 50 mM 
KCl, 1.5 mM MgCl2 overlaid by mllleral 011. After an Initial denatUring step 
of 5 min at 95'C, amplification was performed for 32 cycles at 93'C for 1 
min 55' C for 1 min, and 72' C for 1.5 min. A final incubation for 10 min at 
72' C was made to ensure elongation of the products. Four microliters of a 
1: 1 polymerase chain reaction (PCR) product and formamide.dye was run on 
a 6% denaturing polyacrylamide gel. The gels were then dned and autora-
diograms exposed overnight at -70'C. 
PCR-Based Allele Specific Assays PCR-based allele specific assays 
(PASA) to detect single-base variants [14] :,ere develope~ t? det.ect the Kl 
and K2e variants. The two downstream pnmers used to dlstlllgUiSh the Lys 
r (AAA) to Ile (ATA) mutation in KRTI were 5'-ACACTTATGGA-
GATGCTTT -3' (969-951) and 5' -ACACTT ATGGAGATGCTT A-3' re-
spectively, with 5' -GTCTCT ATGCTTGGGGT AGAGGAGTGTT-
TAGCTCC-3' (655-689) used as the common upstream primer. Numbers 
refer to nucleotide positions in Genbank sequence M98776. Amplification 
was performed for 35 cycles (denaturation 1 min at 95'C, 30 seconds an-
nealing at 55'C, and 1 min extension at 72'C) with 0.1 mM dNTP, 
1.5 mM MgCl2 , 125 ng DNA per 25 Jil mix and 0.1 JIM primers. Primers to 
distinguish the keratin 2e polymorphism (Gly [GGC] versus Asp [GAC]) 
were 5'-ACAACAAATGAATGTTGG-3' (690-707) and 5'-ACAACAA-
ATGAATGTTGA-3', respectively, with 5'-CTTCTTCTTATAATCC-
TCCACAAG-3' (852-829) as the common downstream primer. Nucleo-
ride positions are from Genbank sequence S43646. PCR conditions were the 
, same as above, except for 50'C annealing temperature. 
Keratin Gene Amplification and Sequencing The keratin 1 gene 
exons were analyzed as described previously (8). To ampli fy complete kera-
tin 2e exons, intron sequences were required. Partial intron sequences were 
obtained by sequence analysis of PCR-amplified DNA that had been pre-
I pared using primers based on the published keratin 2e seq~e.nce (15) .. The 
primer sequences for preparation of DNA fragments conta1l1111g kerat1l1 2e 
exons and those for sequencing analysis from these templates are available 
from us on request. 
Homology and Secondary Structure Analysis Alignment of keratin 
sequences was performed using the Macintosh GeneWorks 2.0 (Intelligenc-
tics) utility. Secondary structure predictions utilized algorithms available in 
rhe MacVector 4.0 program (Kodak/IBI). 
RESULTS 
Clinical Studies We investigated a three-generation family in 
which there were 13 affected individuals (Fig 1). After obtaining 
Kl MUTATION IN PALMAR-PLANTAR KERATODERMA 765 
informed consent, a complete dermatologic examination was per-
formed on six affected patients, and blood for DNA obtained from 
11 affected family members, five unaffected, and five spouses. 
The inheritance pattern in the family was consistent with autoso-
mal dominant inheritance, although the observed segregation ratio 
of 0.75 was probably due to ascertainment bias. In adults the disease 
manifested as moderate to severe thickening of the skin on palms 
and soles (Fig 2A). The area of hyperkeratosis usually extended 
along the Achilles tendon of the foot and occasionally along the 
extensor tendon of the great toe. However, involvement stopped 
abruptly at the wrist flexure and at the border of the dorsal aspect of 
the hands and feet. The border of the palmar and plantar hyperkera-
tosis was separated from the normal-appearing skin by an erythema-
tous halo. There were discrete hyperkeratotic pads over several of 
the knuckles of the hands. Some adult patients experienced mild 
limitation of extension of the digits. Patients had a slight beaking 
(concave) deformity of the nails. Three of the four adult patients 
who were examined had dermatophyte infection of the toenails and 
feet, and two had involvement of the palms. Hyperkeratosis of the 
umbilicus and nipple areolae were present, as well as very mild 
thickening and dryness of the knees and elbows. 
Two affected children were examined. These patients had 
presented at birth with mild thickening of the palms and soles. On 
examination, one toddler with a history of atopic dermatitis had 
eczematous changes involving several areas including blistering and 
peeling of the plantar surface. Both children had generalized dry-
ness with fine, powdery scale, and hyperkeratosis of the areolae and 
umbilicus. There was no family history of esophageal carcinoma or 
breast cancer, as has been associated with PPK in other families 
[12,16,17]. 
A 3-mm punch biopsy of the affected palms from four adults and 
one biopsy from an affected elbow were obtained and examined. 
There was hyperkeratosis of the stratum corneum with no evidence 
of epidermolysis characteristic of epidermolytic hyperkeratosis (Fig 
2B). On electron microscopic examination, cells of the granular and 
spinous layers did not show the aggregated tonofilaments or large 
keratohyalin granules characteristic of epidermolytic hyperker-
atosis. 
Linkage Studies The chromosomal region of the type I keratins 
was the initial candidate location for the NEPPK gene in this fam-
ily. Analysis of the segregation of KRTlO size polymorphism [18] , 
and of mtcrosatelltte markers D17S579 and 017S800, showed obli-
gate recombination between each of these loci and the NEPPK 
locus, excluding approximately 40 cM in this region (Table I). 
Linkage to the type II keratin region on chromosome 12 was then 
investigated using size variations in the glycine-rich carboxy-ter-
minal V2 subdomain [1 9] ofKRT1, and restriction fragment length 
polymorphisms in the 012S14 and D12S17 loci. Each of these 
proved uninformative in this family. Therefore, five microsatellite 
markers (D12S85, D12S87, D12S90, 012S96, D12S103) mapped 
to 12q [20] were investigated for linkage to NEPPK. D12S87 was 
uninformative, but the remaining loci showed complete cosegrega-
tion with NEPPK, with D12S90 and 012S103 each giving maxi-
mum lod scores 2: 2.4, and Z = 3.0 for D12S96 (Table I). A haplo-
type constructed from the D12S96, D12S103, and D12S90 loci 
gave a multipoint lod score of 3 .61 at e = 0 with NEPPK. As 
neither the genetic nor physical relationship of these loci to the 
keratin cluster was known, we typed the microsatellites in a large 
reference pedigree in which KRT1 was completely informative 
[6,21]. Although D12S85, D12S96, and D12S103 were largely 
uninformative in the reference pedigree, linkage between D12S90 
and KRT1 was proved (Z = 5.63, e = 0.03). This result implicated 
the type II keratin loci in the etiology of NEPPK. 
Mutation Analysis in Keratins Kl and K2e Having shown 
tight linkage between the type II keratin gene cluster at 12q11-q13 
and markers linked to NEPPK, we undertook mutational analysis of 
the type II keratin genes whose expression is associated with supra-
basal palmar/plantar epidermis. A good disease-gene candidate was 
keratin 2e, which has been shown to be expressed at high levels in 
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Figure 2. NEPPK. A) Patient with NEPPK showing palmar hyperkeratosis. B) Hematoxylin and eosin stained section of formalin-fixed skin from palm of 
patient affected with NEPPK. 
palm and sole epidermis, and also at detectable, but much lower, 
levels in truncal epidermis [15]. Keratin 1, another potential candi-
date, is a significant type II keratin constituent of palmar/plantar 
epidermis, as well as a major component of keratin intermediate 
filaments (KIF) throughout the epidermis. A variety of point muta-
tions in KR T1 had already been shown to be associated with the 
distinct disorder, generalized epidermolytic hyperkeratosis. 
We examined keratin 2e for mutations in NEPPK by amplifying 
each exon using PCR from the purified genomic DNA of affected 
and unaffected family members. These amplified products were 
then sequenced directly. The primers used in our analysis were 
derived from keratin 2e intron sequences. We observed sequence 
heterogeneity at a single base position (G versus A), which indicated 
the presence of either a glycine residue [15] or an aspartic acid in \ 
position 6 of the L1 subdomain. However, this polymorphism did 
not segregate with the disease in the family and was also observed in 
16 alleles of 98 control DNA alleles (49 individuals) tested by a 
PCR-based allele specific assay (PASA) (see Materials arId Methods). 
Table I. Linkage Analysis of NEPPK 
0 0.05 
Chromosome 17 
KRTtO -00 -1.7 
D17S579 -00 -4.4 
D17S800 -00 -1.4 
Chromosome 12 
D12S17 0.6 0.6 
D12S85 1.9 1.7 
D12S96 3.0 2.7 
D12S103 2.6 2.4 
D12S90 2.4 2.2 
Keratin 1 mutation 
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Figure 3. Sequence analysis showing the K73I mutation in the DNA 
of an individual affected with palmar/plantar keratoderma. The 
autoradiogram from direct analysis of PeR-amplified DNA shows seque~ce 
heterogeneity (both A and T) at a position yielding c?dons for both lysme 
and isoleucine at amino acid residue 73 of the keratm 1 gene of affected 
individuals. Only the normal A is seen in the DNA from an unaffected 
family member. 
The sequence of the KRTI gene was analyzed. DNA from an 
affected individual revealed a single base substitution (AAA to AT A) 
causing a lysine to isoleucine change in codon 73 (~esignat~d K73I) 
located in the variable subdomain, VI, of the ammo-termmal end 
domain of keratin 1 (Fig 3). No sequence variations were found in 
the HI subdomain, nor in the entire rod domain, regions where all 
previous disease-causing mutations in keratin genes have been i~en­
tified (Fig 4), nor in the V2 or H2 regions of the car?oxy-terml~lal 
domain. A previously described common polymorphism at posltlon 
11 of the E2 domain (arginine, AGG or lysine, AGA) was segregat-
ing in the family [8]. 
To confirm that the K731 variation segregated with NEPPK, a 
peR allele-specific assay was developed using a common u~stre.am 
primer, and either a wild-type specific re~erse primer (terrrunatm.g 
in a complimentary T) or a mutation-specific reverse pnmer. (terml-
nating in an A). As seen in Fig 5, amplification with the wtld-type 
primer generated an amplified fragment from the DNA of b<:>th 
normal and affected individuals, whereas the mutant-specific 
primer only yielded an amplification product from the DNA. of 
affected individuals. Complete cosegregation of the K731 mutatIOn 
with the disease in the family was observed yielding a lod score of 
El H 1 lA 1 B 
L 1 
) 
(??) 143 36 35 12 101 
- a.-helical 
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4.2 at e = 0 (Table I). The PASA analysis was used to demonstrate 
that this variant was not present in 50 unrelated individuals not 
having PPK (data not shown). 
Mutated Lysine Lies in a Highly Conserved Portion of the Vl 
Subdomain of Most Type II Keratins To assess the signifi-
cance of the K731 mutation, the amino-terminal sequences ofkera-
tins were evaluated for sequence homologies. Common subdomain 
features have been described for type I and type II keratins and are 
indicated in the representation of keratin 1 in Fig 4 [22,23]. The 
K731 mutation occurs within the 143-residue El/Vl region of the 
protein (Fig 4). Sequence alignment revealed striking conservation 
over a 22-residue contiguous region within the VI subdomain of 
seven human type II keratins (Fig 6) and four homologous keratins 
in other species (not shown). Only keratin 7 and keratin 8 lack this 
sequence. The mutation in the NEPPK family alters the invariant 
lysine at position 15 of this sequence. Preceding this residue is the 
only variable position within the conserved region, which separates 
a 13-residue conserved segment from an 8-residue conserved seg-
ment. We propose this 22-residue conserved sequence be termed 
the keratin ISIS box. A search of sequence databases for the existence 
of the keratin ISIS box in other proteins revealed only very partial 
homologies with either segment. 
DISCUSSION 
We describe a family with hyperkeratosis of the palms and soles, 
and limited involvement of the areola, umbilicus, and knuckle pads 
on the dorsal aspects of the finger joints. Histologic examination 
revealed the absence of epidermolysis, and defined this family as 
having NEPPK. Gene linkage and mutation analysis showed that a 
point mutation in exon 1 of KRTl, resulting in the substitution 
K731, is the likely cause of the disease. 
Mutations in KRT9 have been described in epidermolytic hyper-
keratosis limited to the palms and soles (EPPK) [11,12]. Although 
the palmar-plantar involvement of the family in this report resem-
bles those with KR T9 mutations, the histologic findings are differ-
ent. Those families in whom KRT9 mutations have been identified 
have a characteristic histologic picture termed "epidermolytic hy-
perkeratosis," whereas four biopsies from the family reported here 
lack this distinctive histologic feature. Further, our family also has 
involvement of areola and umbilicus, mild involvement over the 
knuckles of the hands, and mild thickening and dryness of knees and 
elbows-features that have not been reported in the KRT9-mu-
tated families. The NEPPK in our family is consistent with that 
described previously [1,2] and called Unna-Thost disease. Our data 
suggests that NEPPK is distinct genetically from EPPK (Vomer 
type) as well. The involvement of locations other than palms and 
soles in our NEPPK family are inconsistent with the reported ex-
pression of keratin 9, which is limited to palmar/plantar epidermis 
and a few glandular structures [24]. On the other hand, keratin 1 is 
widely expressed throughout the epidermis. 
We and others have reported mutations in the epidermal keratins 
KRT1 [5,6,8,9] and KRTI0 [5,7,10] in generalized epidermolytic 
hyperkeratosis. The clinical phenotype in this family differs from 
V2 E2 
17 19 8 121 20 118 13 
313 
rod domain 
Figure 4. Structural features of keratin 1. All keratins have a central rod domain (about 310 residues) comprised of helical coiled-coil segments (designated 
lA, lB, 2A, 2B) interrupted by non-helical short linker segments (11, 112, L2). The central region is flanked by the homology regions Hl and H2 (the latter in 
type II keratins only) and by variable length end domain sequences that can generally be subdivided into end sequences (El, E2) and variable regions (Vl, V2) 
on the basis of amino acid character. The number of residues in the subdomains of keratin 1 are shown. A precise El / Vl boundary in keratin 1 cannot be 
defined. The K731 mutation (arrow) and the conserved 22 residue segment (stripes) are shown in Vl. 
768 KIMONIS ET AL 
111-6 11-4 11-3 111-9 IV-5 
----




.'; 111-4 111-5 
~ ~ Wt M Wt M 
IV-3 IV-4 
Wt M Wt M 
325-
Figure 5. PCR allele specific assay for the presence of the K731 
mutation. The normal or mutant alleles were amplified from genomic 
DNA in separate PCR reactions using either the wildtype-specific reverse 
primer (left lane of each pair) or the mutant-specific reverse primer (right 
lane of each pair) and a common forward primer. Unaffected family mem-
bers yielded amplification of the expected 325 bp DNA fragment for the 
wildtype-specific primers only, whereas affected individuals (bold) gave 
bands with both sets of primers. Analyzed individuals are designated accord-
ing to the pedigree in Fig 1. 
the others in whom KRTl mutations have been defined. Adult 
patients in the family reported by Compton et af [21] in whom a 
keratin 1 mutation was found in the Hl subdomain [6] had primar-
ily palmar and plantar hyperkeratosis. They often experienced blis-
tering, especially with trauma. Children in the family had moderate 
involvement of the flexural areas of the skin and the corners of the 
lips, with a ridge pattern of scale. In the report by Yang et af [8] 
keratin 1 mutations were reported in three epidennolytic hyperker-
atosis pedigrees. One family had clinical findings nearly identical to 
the one described in Compton et af [21]. Two patients in different 
kindreds had severe generalized disease with erythroderma, hyper-
keratosis, and contractu res of the palms and digits. The mother and 
son described by Rothnagel et af [5] with a KRTl mutation had 
disseminated hyperkeratotic lesions over joints, hands, and feet and 
rare neonatal blistering. Histopathologic examination confirmed 
epidermolytic hyperkeratosis in each of these reported cases, in con-
trast to the family presented here. 
The specific region of the keratin 1 protein affected by mutation 
may be a major determining factor in the different clinical and 
histologic consequences of the KRTl mutation. All of the 31 dif-
ferent mutations in keratins described previously [25] have been in 
four subdomains of the central a-helical rod domain of the proteins 
(Hl , lA, L12, 2B), and all have been in disorders characterized by 
loss of cell integrity (epidermolysis bullosa simplex, generalized 
epidermolytic hyperkeratosis, EPPK). The mutation described in 
this paper is the first outside these regions, and the disease in this 
family is both clinically and histologically distinct. 
Several observations make it likely that mutations in the Hl, lA, 
L12, and 2B subdomains affect KIF stability and integrity. These 
subdomains are involved in dimerization of type I and II keratin 
chains to form the basic molecule, and the higher-order interactions 
between molecules in KIF . A recent structural model for molecule 
interactions in KIF, based upon filament assembly and cross-linking 
studies, predicts an overlap between the first 10 residues of 1A of 
one molecule with the last 10 residues of the 2B subdomain of an 
adjacent molecule, residues where the majority of disease mutations 
have been found . A role for the H 1 subdomain in filament assembly 
has also been suggested [26] . In addition, single-amino acid substi-
tutions corresponding to disease mutations in the Hl, lA, and 2B 
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subdomains have been shown to impair the capacity of synthetic 
peptides to disaggregate preformed filaments [6 ,8,10,27]' and KIF 
assembled in. vitro with keratin chains carrying lA mutations have 
abnormal structure [28,29]. 
In contrast, the function of the variable end domains of keratins is 
poorly understood. Evidence against a role in filament assembly, 
however, has been reported . In an i" vitro study of K5/K14 KIF 
formation [30] deleting the first 71 residues of the VI region of 
keratin 5 (including 20 residues of the 22-residue ISIS box) had no 
detectable effect on fil ament assembly or structure. In another study 
[31], deletion of the head domain of keratin 7 (which lacks an ISIS 
box) did not interfere with K7/K18 filament formation . This 
argues against a significant role for Vl or the ISIS box in filament 
structure. It is expected, therefore, that the V1 region must have 
another function in epidermal cells. Our identification of a highly 
conserved 22-residue sequence in VI suggests a common function 
of this segment among most type II keratins (Fig 6). If so, then the 
absence of the ISIS box from keratins 7 and 8 implies specific differ-
ences in KIF interactions in simple epithelia and other cells express-
ing only these type II keratins. 
How might the K731 mutation affect the function of keratin 1 
and IFs? The VI region consists mostly of short glycine loops flank-
ing the conserved segment [32]. Secondary structure predictions of 
VI are largely unrevealing because of the relative lack of order 
inherent in such structures . However, analysis of the region encom-
passing the ISIS box predicts a non-helical structure: a short /J-turn, 
followed by a ,B-sheet and then another turn. The introduction of 
isoleucine for lysine predicts a shortening of the second turn. 
Whether it is the change in secondary structure or the non-conser-
vative substitution of a hydrophobic isoleucine for charged lysine, 
normal interactions of KIF within the epidermis may be disturbed. 
Although the nature of interactions of KIF within the epidermis 
have not been fully elucidated, one possibility is an effect on KIF-
desmosome junctions. An effect on post-translational modification, 
for example, phosphorylation, could also alter protein function. 
The presence of a charged lysine in proximity to serine is character-
istic of phosphorylation sites. However, the specific motifs recog-
nized by known kinases are not found in the ISIS box of keratin 1, 
and phosphorylation was in fact not detected in one study [33]. An 
alternative possibility is that the invariant lysine in the VI region is 
involved in crosslinking of keratins onto the cornified envelope via 
the action of epidermal transglutaminases [34]. The inability to 
crosslink a lllutated keratin at this site may interfere with normal 
function of the cornified layer, and lead to hyperkeratosis . 
Our study of NEPPK has revealed the first keratin mutation 
where the effect on epidermal differentiation, namely, hyperkera-
tosis, is probably not due to destabilization of KIF assembly. The 
specific disruption of keratin 1 function remains to be determined. 
Further correlation of specific keratin mutations with clinical and 
histologic phenotypes should continue to contribute to progress in 
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"GGGSFGAG GGFGSRSL VNLGG S KS ISISVA RGGGRGSGF " 
" A CGFRSGA G S FGSRSLYNLG SN KSISI S VA AGSSRAGGF " 
"GGGGG F GG GGFGSRSL VG LGG T KSISISVA GGGGGFGAA " 
"AYGFRSGA GGFGSRSLYNLGG DKSISISVA AGGSRAGGF " 
"GG A GRCSS GG F GSRSLYNL RG NKSIS MSVA GSRQGACFG " 
"SLAGACG V GG YGSRSLYNLGG S K R ISI S TR GGSFRNRFG " 
"GLGGACGG A GFGSRSLY GLGG S K R ISI GGG SCAISGGYG " 
Figure 6. Alignment of a portion of the El/Vl end domain se-
quences of seven human type II keratins obtained from GenBank 
data files. Sequences are aligncd to maximize homology and shaded resi-
dues denote regions of particular identity or homology. For each keratin, the 
starting and ending residue positions within the sequence are given. The 
isoleucine substitution for lysine 73 of keratin 1 found in the NEPPK pedi-
gree is indicated. Consensus residues (> 70%) are given for the 22 residue 
segmcnt of greatest homology, termed the keratin ISIS box (see text). 
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nderstanding the relationship between keratin structure, KIF for-~ation, and KIF function in normal and diseased skin. 
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